. Author manuscript; available in PMC: 2022 Dec 1.

Published in final edited form as: J Subst Abuse Treat. 2021 Jun 16;131:108537. doi: 10.1016/j.jsat.2021.108537

Table 3.

Unadjusted intent-to-treat multilevel models of clinical outcomes by condition

	Insomnia Symptoms			Sleep Efficiency			Cannabis-Related Problems			Average Daily Cannabis Use
	B	95% CI	SE	B	95% CI	SE	B	95% CI	SE	B	95% CI	SE
Intercept (Baseline)	15.99^***	14.47, 17.52	.78	.72^***	.65, .78	.04	5.53^***	3.87, 7.19	.85	3.45^***	2.51, 2.66	.48
Condition	−.95	−2.99, 1.10	1.04	.01	−.09, .11	.05	−.68	−2.93, 1.56	1.15	−.92	−2.19, .36	.65
Session	−.16	−2.51, −1.45	.90	.00	−.01, .01	.01	.08	−1.46, 1.63	.79	−.33	−.77, .12	.23
Condition by session	1.10^**	.47, 1.74	.32	−.03	−.07, .01	.02	.65^*	.14, 1.15	.26	.07	−.08, .22	.08

Note.

^*=

p<.05;

^**=

p<.01;

^***=

p<.001.

Treatment condition (0=Brief Behavioral Treatment for Insomnia, 1=Waitlist Control).

SE=standard error.